×
Hero Background

Tumor Necrosis Factor Alpha Inhibitors Companies

ID: MRFR/Pharma/4090-HCR
128 Pages
Rahul Gotadki
October 2025

At the forefront of immunology, Tumor Necrosis Factor Alpha Inhibitors companies focus on developing biologic therapies to modulate the immune system. These organizations contribute to the management of autoimmune conditions by targeting TNF-alpha, a key inflammatory mediator.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Tumor Necrosis Factor Alpha Inhibitors Market Research Report–Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Tumor Necrosis Factor Alpha Inhibitors Market

Tumor Necrosis Factor Alpha Inhibitors Market

 


Latest Tumor Necrosis Factor Alpha Inhibitors Companies Updates:


Pfizer: Launch of XELJANZ (tofacitinib) for ankylosing spondylitis treatment shows continued expansion beyond rheumatoid arthritis.


Janssen: Collaborative effort to transform infliximab (Remicade) into an oral capsule for irritable bowel disease showcases the push towards patient-friendly options.


AbbVie: Patent expiry for Humira (adalimumab) in 2023 leads to increased competition from biosimilars, impacting market share.


Emerging players: Companies like Momenta Pharmaceuticals and HanAll Biopharma are entering the market with biosimilar versions of existing TNF-alpha inhibitors, driving down costs.


List of Tumor Necrosis Factor Alpha Inhibitors Key companies in the market:



  • AbbVie Inc. (U.S.)

  • Ablynx (Belgium)

  • ApogenixGmBH (Germany)

  • AryoGen Biopharma (U.S.)

  • Bionovis (Brazil)

  • CASI Pharmaceuticals (U.S.)

  • Celltrion Healthcare (South Korea.)

  • Celgene Corporation (U.S.)

  • Delenex Therapeutics (Switzerland)

  • Dexa Medica (Indonesia)

  • EPIRUS Biopharmaceuticals (U.S.)

  • Janssen Biotech (U.S.)

  • GlaxoSmithKline Inc. (U.S.)

  • HanAll Biopharma (South Korea.)

  • Intas Pharmaceuticals (India)

  • LEO Pharma (Denmark)